Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Orthopediatrics (KIDS) Return on Sales (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Return on Sales for 10 consecutive years, with 0.16% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales rose 14.0% to 0.16% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.17%, a 2.0% increase, with the full-year FY2025 number at 0.17%, up 2.0% from a year prior.
  • Return on Sales was 0.16% for Q4 2025 at Orthopediatrics, up from 0.19% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.53% in Q3 2022 to a low of 0.48% in Q1 2021.
  • A 5-year average of 0.14% and a median of 0.15% in 2024 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: soared 62bps in 2022, then tumbled -65bps in 2023.
  • Orthopediatrics' Return on Sales stood at 0.0% in 2021, then crashed by -8826bps to 0.25% in 2022, then increased by 30bps to 0.18% in 2023, then tumbled by -72bps to 0.31% in 2024, then surged by 46bps to 0.16% in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Return on Sales are 0.16% (Q4 2025), 0.19% (Q3 2025), and 0.12% (Q2 2025).